Phase
Condition
Turner Syndrome
Hypogonadism
Severe Short Stature
Treatment
Human Growth Hormone
Vosoritide Injection
Clinical Study ID
Ages 3-11 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants must be ≥ 3 years old, and < 10 years old (females) or < 11 years old (males),at the time of signing the informed consent form
A genetically confirmed diagnosis of Turner syndrome, SHOX deficiency or Noonansyndrome.
A height assessment corresponding to a height Z score of ≤ -2.00 SDs in reference tothe general population of the same age and sex.
Tanner Stage 1, at time of signing the ICF.
Have been receiving continuous hGH for the treatment of short stature associatedwith their condition for a minimum of 1 year immediately prior to enrollment.
Are willing to continue on hGH for the Baseline Growth Phase, and for 2 years postrandomization if randomized to the hGH arm.
Inadequate response to prior hGH treatment.
Exclusion
Exclusion Criteria:
Participants with Turner syndrome known to have Y-chromosome material unless theyhave undergone gonadectomy and have fully external female genitalia.
Diagnosis of systemic disease or condition that may cause short stature other thanTurner syndrome, SHOX deficiency, or Noonan syndrome, eg, renal, neoplastic,pulmonary, cardiac, gastrointestinal, immunologic and metabolic disease.
Bone age advanced beyond chronological age by more than 2 years.
Congenital heart disease which places the participant at increased risk of anadverse cardiac outcome in the setting of hypotension,
Have an unstable condition likely to require surgical intervention during the study.
Evidence of decreased growth velocity (AGV < 1.5 cm/year) as assessed over a periodof at least 6 months and growth plate closure assessed using bilateral lowerextremity X-rays.
Previous limb-lengthening surgery, or planned or expected to have limb lengtheningsurgery during the study period.
Planned or expected bone-related surgery (ie, surgery involving disruption of bonecortex, excluding tooth extraction), during the study period.
Study Design
Study Description
Connect with a study center
Angers University Hospital Center
Angers, Maine-et-Loire 49 933
FranceActive - Recruiting
CHU de Toulouse - Hôpital des Enfants
Toulouse, Occitanie
FranceActive - Recruiting
Central University Hospital of Asturias
Oviedo, Asturias 33011
SpainSite Not Available
Children's Hospital Colorado
Aurora, Colorado 80045
United StatesActive - Recruiting
Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children)
Wilmington, Delaware 19803
United StatesActive - Recruiting
Nicklaus Children's Hospital
Miami, Florida 33155
United StatesSite Not Available
St. Luke's Children's Endocrinology and Diabetes
Boise, Idaho 83712
United StatesActive - Recruiting
Kentucky Children's Hospital
Lexington, Kentucky 40506
United StatesActive - Recruiting
New York Medical College
Boston, Massachusetts 02115
United StatesActive - Recruiting
M Health Fairview Pediatric Specialty Clinic - Explorer
Minneapolis, Minnesota 55454
United StatesActive - Recruiting
Children's Hospital at Montefiore
Bronx, New York 10467
United StatesActive - Recruiting
Atrium Health Carolinas Medical Center
Charlotte, North Carolina 28203
United StatesActive - Recruiting
University of Texas Health Science Center at Houston (UT Health)
Houston, Texas 77030
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.